Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials (Q6644034)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials |
scientific article; zbMATH DE number 7949934
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials |
scientific article; zbMATH DE number 7949934 |
Statements
Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials (English)
0 references
27 November 2024
0 references
adaptive randomization
0 references
Bayesian phase I--II design
0 references
continuous dose levels
0 references
drug combination
0 references
escalation with overdose control (EWOC)
0 references
